GA NCORP

Treatment Sites

Northside Hospital Cancer Institute - Forsyth

Treatment Sites


Primary Location

1200 Northside Forsyth Drive
Suite 140
Cumming, GA 30041
770-292-7000 (p)
www.northside.com

driving directions

Clinical Trials

DSC-MRI in Measuring Relative Cerebral Blood Volume for Early Response to Bevacizumab in Patients with Recurrent Glioblastoma
Cancer Type: Brain & Spinal Cord Tumor

Durvalumab vs Placebo With Stereotactic Body Radiation Therapy in Early Stage Unresected Non-small Cell Lung Cancer Patients
Cancer Type: Lung Cancer

Ipilimumab and Decitabine in Treating Patients with Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
Cancer Type: Leukemia, Myelodysplastic Syndromes (MDS)

National Cancer Institute “Cancer Moonshot Biobank”
Cancer Type: Hematopoietic Malignancies, Lung Cancer, Multiple Myeloma, Solid Tumor

Observation or Radiation Therapy in Treating Patients with Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Cancer Type: Brain & Spinal Cord Tumor

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients with Bone Metastasis
Cancer Type: Bone Tumor, Breast Cancer

Testing Ramipril to Prevent Memory Loss in People with Glioblastoma
Cancer Type: Brain & Spinal Cord Tumor

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, ALCHEMIST Chemo-IO Study
Cancer Type: Lung Cancer

Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
Cancer Type: Unknown Primary, Uterine Cancer

Testing Whether Avoiding the Hippocampus During Whole-Brain Radiation Therapy Prevents Cognitive Side Effects in Patients with Small Cell Lung Cancer
Cancer Type: Lung Cancer

Tissue Collection and Natural History Study of Patients with Myelodysplastic Syndrome or Myeloproliferative Neoplasms
Cancer Type: Cancer-Related Syndrome, Leukemia, Myelodysplastic Syndromes (MDS)